
Please try another search
4SC AG, a biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany and internationally. The company develops Resminostat, an orally administered histone deacetylase inhibitor for the treatment of cutaneous T-cell lymphoma. It also out-licenses and partnered drug candidates to pharma and biotech companies. The company was founded in 1997 and is headquartered in Planegg, Germany.
Name | Age | Since | Title |
---|---|---|---|
Helga Rübsamen-Schaeff | 75 | 2014 | Independent Member of Supervisory Board |
Charles B. Epstein | - | - | Member International Scientific Expert Panel |
Clemens M. Doppler | 65 | 2005 | Independent Chairman of Supervisory Board |
Irina A. Antonijevic | 59 | 2012 | Independent Member of Supervisory Board |
Wolff Schmiegel | - | - | Member International Scientific Expert Panel |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review